CWG
ABBV icon

Crown Wealth Group’s AbbVie ABBV Stock Holding History

Crown Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$644K Buy
2,560
+5
+0.2% +$1.08K 0.16% 64
2026
Q1 		$556K Buy
2,555
+115
+5% +$25.5K 0.16% 63
2025
Q4 		$558K Buy
2,440
+277
+13% +$63.1K 0.16% 63
2025
Q3 		$501K Buy
2,163
+8
+0.4% +$1.63K 0.15% 67
2025
Q2 		$400K Buy
2,155
+94
+5% +$17.5K 0.15% 69
2025
Q1 		$432K Buy
2,061
+110
+6% +$21.4K 0.22% 55
2024
Q4 		$347K Buy
1,951
+45
+2% +$8.27K 0.14% 75
2024
Q3 		$376K Sell
1,906
-48
-2% -$8.96K 0.16% 71
2024
Q2 		$335K Buy
1,954
+100
+5% +$16.6K 0.17% 71
2024
Q1 		$338K Buy
1,854
+545
+42% +$93.9K 0.17% 64
2023
Q4 		$203K Buy
+1,309
New +$191K 0.12% 92

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Crown Wealth Group's ABBV Position: Q2 2026 in Review

Crown Wealth Group increased its AbbVie (ABBV) stake by 0.2% in Q2 2026, buying an estimated $1.08K and bringing the position to 2,560 shares worth $644K. The position accounts for 0.16% of the portfolio, ranked #64.

Crown Wealth Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Crown Wealth Group held 2,560 shares of AbbVie worth $644K as of Q2 2026.
  • Crown Wealth Group bought 5 AbbVie shares in Q2 2026, an estimated $1.08K.
  • AbbVie made up 0.16% of Crown Wealth Group's portfolio in Q2 2026, its #64 holding.
  • Crown Wealth Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Crown Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.